Growth Capital For Life Sciences & Healthcare
Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to drive growth and profitability while maintaining the vision and integrity of the organization.
We seek to partner with innovative companies by providing capital and strategic guidance to help them grow.
Latest News & Announcements
Nimble Therapeutics Announces Achievement of Development Milestones from Multiple Partnered Programs Connected to a Strategic Large Pharma Collaboration
MADISON, WI, USA, [05/17/2022] — Nimble Therapeutics Inc. today announced the company has achieved the first development milestone for each of several programs attached to a multi-target collaboration with an undisclosed large pharma partner. Nimble will receive payments for each milestone connected [...]
bioMérieux strengthens its commitment to fight antimicrobial resistance with the acquisition of Specific Diagnostics, an innovative company focusing on fast AST solution
Marcy l’Étoile, France, April 12th 2022 – bioMérieux, a world leader in the field of in vitro diagnostics, announces that it has entered into an agreement to acquire Specific Diagnostics, a privately held U.S. based company that has developed a rapid antimicrobial susceptibility test (AST) system th [...]
AmerisourceBergen and TrakCel Launch Integrated Platform to Support Cell and Gene Therapies
The integration of TrakCel’s OCELLOS and Lash Group’s Fusion aims to improve speed-to-therapy by increasing connectivity between providers and hub patient services Conshohocken, Pa. (January 25, 2022) – AmerisourceBergen, a global healthcare solutions leader, and TrakCel, the leading innovator of ce [...]